Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Frontline Plc Ordinary Shares (FRO) vs Novavax Inc (NVAX) Price & Performance

Frontline Plc Ordinary SharesTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Frontline Plc Ordinary Shares vs Novavax Inc — how do they compare? Frontline Plc Ordinary Shares trades at $55.72 (market cap $11.81B), while Novavax Inc trades at $11 (market cap $1.85B). The key difference: Frontline Plc Ordinary Shares is far larger — about 6.4× Novavax Inc's market cap, and Frontline Plc Ordinary Shares pays a 10.14% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Frontline Plc Ordinary Shares for 0 Days and Novavax Inc for 59 Days on average.

FRONVAX
Market Cap
$11.81B$1.85B
Volume
3,013,0868,362,562
Sector
IndustrialsHealth
52-Week High
$56.26$12.56
52-Week Low
$20.58$6.22
Typical Hold Time
0 Days59 Days
Enterprise Value
$13.92B$1.43B
Dividend Yield
10.14%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Frontline Plc Ordinary Shares

No Aura AI signal available yet.

Novavax Inc

Novavax (NVAX) trades at $11.01, down 2.74% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported strong revenue of $1.12B in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Recent news highlights the company's pivot to a partnership-driven model using its Matrix-M adjuvant technology, with regulatory approvals for its updated COVID-19 vaccine in major markets.

Investment outlook remains speculative with analyst consensus heavily favoring Buy ratings (73.92%) but fundamental risks persist including negative cash flow trends and high debt levels. The stock offers potential upside from partnership expansions but faces significant execution and competitive risks in the biopharma sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FRO
77% Buy23% Sell
Avg holding period · 0 Days
NVAX
59% Buy41% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About Frontline Plc Ordinary Shares

Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.

Read more on FRO →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX →